Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference

Paulus Kirchhof; Gregory Y. H. Lip; Isabelle C. Van Gelder; Jeroen Bax; Elaine Hylek; Stefan Kaeaeb; Ulrich Schotten; Karl Wegscheider; Giuseppe Boriani; Michael D. Ezekowitz; Hans-Christoph Diener; Hein Heidbuchel; Deirdre A. Lane; Luis Mont; Stephan Willems; Paul Dorian; Panos Vardas; Guenter Breithardt; A. John Camm

doi:10.1160/TH11-07-0517

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference

Paulus Kirchhof^*, Gregory Y. H. Lip, Isabelle C. Van Gelder, Jeroen Bax, Elaine Hylek, Stefan Kaeaeb, Ulrich Schotten, Karl Wegscheider, Giuseppe Boriani, Michael D. Ezekowitz, Hans-Christoph Diener, Hein Heidbuchel, Deirdre A. Lane, Luis Mont, Stephan Willems, Paul Dorian, Panos Vardas, Guenter Breithardt, A. John Camm

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

65 Citations (Web of Science)

Abstract

There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

Original language	English
Pages (from-to)	1012-1019
Journal	Thrombosis and Haemostasis
Volume	106
Issue number	6
DOIs	https://doi.org/10.1160/TH11-07-0517
Publication status	Published - Dec 2011

Keywords

Acquired coagulation disorders
vitamin K-dependent factors
stroke / prevention
thrombin
atrial fibrillation

Access to Document

10.1160/TH11-07-0517

Cite this

Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaeaeb, S., Schotten, U., Wegscheider, K., Boriani, G., Ezekowitz, M. D., Diener, H-C., Heidbuchel, H., Lane, D. A., Mont, L., Willems, S., Dorian, P., Vardas, P., Breithardt, G., & Camm, A. J. (2011). Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference. Thrombosis and Haemostasis, 106(6), 1012-1019. https://doi.org/10.1160/TH11-07-0517

@article{2212cf0b388b486bb25a926eaa8e2d25,

title = "Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference",

abstract = "There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.",

keywords = "Acquired coagulation disorders, vitamin K-dependent factors, stroke / prevention, thrombin, atrial fibrillation",

author = "Paulus Kirchhof and Lip, {Gregory Y. H.} and {Van Gelder}, {Isabelle C.} and Jeroen Bax and Elaine Hylek and Stefan Kaeaeb and Ulrich Schotten and Karl Wegscheider and Giuseppe Boriani and Ezekowitz, {Michael D.} and Hans-Christoph Diener and Hein Heidbuchel and Lane, {Deirdre A.} and Luis Mont and Stephan Willems and Paul Dorian and Panos Vardas and Guenter Breithardt and Camm, {A. John}",

year = "2011",

month = dec,

doi = "10.1160/TH11-07-0517",

language = "English",

volume = "106",

pages = "1012--1019",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Georg Thieme Verlag",

number = "6",

}

Kirchhof, P, Lip, GYH, Van Gelder, IC, Bax, J, Hylek, E, Kaeaeb, S, Schotten, U, Wegscheider, K, Boriani, G, Ezekowitz, MD, Diener, H-C, Heidbuchel, H, Lane, DA, Mont, L, Willems, S, Dorian, P, Vardas, P, Breithardt, G & Camm, AJ 2011, 'Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference', Thrombosis and Haemostasis, vol. 106, no. 6, pp. 1012-1019. https://doi.org/10.1160/TH11-07-0517

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference. / Kirchhof, Paulus; Lip, Gregory Y. H.; Van Gelder, Isabelle C. et al.

In: Thrombosis and Haemostasis, Vol. 106, No. 6, 12.2011, p. 1012-1019.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference

AU - Kirchhof, Paulus

AU - Lip, Gregory Y. H.

AU - Van Gelder, Isabelle C.

AU - Bax, Jeroen

AU - Hylek, Elaine

AU - Kaeaeb, Stefan

AU - Schotten, Ulrich

AU - Wegscheider, Karl

AU - Boriani, Giuseppe

AU - Ezekowitz, Michael D.

AU - Diener, Hans-Christoph

AU - Heidbuchel, Hein

AU - Lane, Deirdre A.

AU - Mont, Luis

AU - Willems, Stephan

AU - Dorian, Paul

AU - Vardas, Panos

AU - Breithardt, Guenter

AU - Camm, A. John

PY - 2011/12

Y1 - 2011/12

N2 - There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

AB - There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

KW - Acquired coagulation disorders

KW - vitamin K-dependent factors

KW - stroke / prevention

KW - thrombin

KW - atrial fibrillation

U2 - 10.1160/TH11-07-0517

DO - 10.1160/TH11-07-0517

M3 - Article

C2 - 22048744

SN - 0340-6245

VL - 106

SP - 1012

EP - 1019

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 6

ER -